MMJ Recs

NOVEMBER 17, 2023

It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. MMJ is known for its efficacy in treating various medical issues, including chronic pain, epilepsy, multiple sclerosis, and more. It oversees licensing, quality control, and patient access.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

JUNE 23, 2021

The analysis of patient-reported outcome measures following treatment with cannabis-based medicinal products (CBMPs) in a study covering patients with all conditions found statistically significant improvements in anxiety, sleep , and general quality of life at one, three, and six months following treatment, compared to baseline assessment.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

Cannabis Law Report

APRIL 12, 2019

I use medical cannabis for my skin, pain, mood, fatigue, appetite and, most importantly, sleep. I have successfully reduced 85% of my opioid use for chronic pain as the result of arthritis through several surgeries and medical cannabis. Patient advocacy is alive and well in Canada.

Access 45

Access Patients Marijuana Medicine 45

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Pain and chronic pain were the most common conditions mentioned over the time period and were referred to in 62% of all articles.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

SEPTEMBER 23, 2019

Therefore, the AAFP advocates for further research into the overall safety and health effects of recreational use, as well as the effects of those laws on patient and societal health. The AAFP supports requirements testing current marijuana and cannabinoid products for safety, dosing, and product consistency. In the Exam Room.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

The Cannigma

JANUARY 19, 2022

Today on the show we welcome Nikki Lawley, a Traumatic Brain Injury Survivor, and founder of NIKKI and the Plant, an advocacy group for medical marijuana use, with a special focus on helping women who have suffered a TBI. I mean, asking questions was like, how can I function, how can I sleep, how can I not be in pain.

Patients 83

Patients Compliance Compliance Cannabis 83

The Cannigma

DECEMBER 12, 2022

Clinical research: Mescaline is not easy to use clinically because of its slow onset and long duration, but clinical trials are being organized for addiction, PTSD, and chronic pain. Stage three lasts up to 72 hours after ingestion, and is characterized by mild stimulation, heightened awareness and disrupted sleep.

History 119

History Microdosing Research and Development Clinical Trials 119